The largest database of trusted experimental protocols

Tesr1 medium

Manufactured by STEMCELL
Sourced in Germany

TESR1 is a defined, serum-free medium for the maintenance and expansion of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). It contains the necessary components to support the growth and self-renewal of undifferentiated stem cells.

Automatically generated - may contain errors

2 protocols using tesr1 medium

1

Random Differentiation of H9 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To remove MEFs, H9 cells from the maintenance culture were transferred on hESC-qualified matrix (BD Biosciences, California, USA)-coated, 60-mm tissue culture plates (Nunc, Langenselbold, Germany) in TESR1 medium (StemCell Technologies) and were maintained for 5 days prior to differentiation. The random differentiation into embryoid bodies (EBs) representing multiple lineages was performed as described previously (Meganathan et al. 2012 (link)). In brief, cell clumps were obtained by cutting and scraping the cells with a passage tool (StemPro EZPassage™ Disposable, Invitrogen) and a cell scraper. On day 0, 80 clumps were seeded in each well of a pluronic-coated, v-bottom plate in 100 µl of random differentiation (RD) medium (DMEM-F12 medium with 20 % KO serum replacement, 1 % non-essential amino acids, penicillin (100 units/ml), streptomycin (100 µg/ml) and 0.1 mM β-mercaptoethanol) containing chemical or vehicle, and the plate was then incubated (37 °C, 5 % CO2) for 4 days. The EBs were collected on day 4 and were transferred onto a 100-mm bacteriological plate in 15 ml of RD medium containing the chemical or vehicle. The medium was replenished every alternate day until day 14 of differentiation.
+ Open protocol
+ Expand
2

Generating Human iPSCs from Bone Marrow MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs was generated by reprogramming primary human bone marrow-derived MSCs (hBM-MSCs) as previously described (Diederichs and Tuan, 2014 (link)). The hBM-MSCs were isolated from a 48 year-old donor. We obtained hBM-MSCs from the femoral heads of patients undergoing total hip replacement with the Institutional Review Board's approval (University of Washington, Seattle, WA). The phenotype and differentiation capacity of iPSCs have been reported in a previous study (Diederichs and Tuan, 2014 (link)). The expansion of iPSCs were carried out according to standard protocol. Briefly, vitronectin XF (Stemcell Technologies, Vancouver, CA) was used to coat the culture plate before seeding of iPSCs. iPSCs were then fed with TeSR1 medium (Stemcell Technologies, Vancouver, CA). The medium was changed daily and cells were passaged at 80–90% confluency.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!